Quick Answer
NEKTAR THERAPEUTICS reported Total Assets of $280.41 million for fiscal year 2025.
NEKTAR THERAPEUTICS Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $280.41M | -7.7% |
| 2024 | $303.85M | -23.7% |
| 2023 | $398.03M | -44.0% |
| 2022 | $710.60M | -36.4% |
| 2021 | $1.12B | -27.4% |
| 2020 | $1.54B | -22.2% |
| 2019 | $1.98B | -8.0% |
| 2018 | $2.15B | +322.5% |
| 2017 | $508.87M | -10.5% |
| 2016 | $568.87M | +14.1% |
| 2015 | $498.64M | +12.9% |
| 2014 | $441.62M | +1.6% |
| 2013 | $434.53M | -12.7% |
| 2012 | $497.79M | -17.9% |
| 2011 | $606.55M | +16.4% |
| 2010 | $521.23M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $301.35M | -2.1% | +45.2% |
| June 30, 2025 | $207.53M | -39.6% | -19.0% |
| March 31, 2025 | $256.24M | -35.3% | -15.7% |
| December 31, 2024 | $303.85M | -23.7% | -1.3% |
| September 30, 2024 | $307.97M | -30.4% | -10.3% |
| June 30, 2024 | $343.33M | -30.5% | -13.3% |
| March 31, 2024 | $396.01M | -29.5% | -0.5% |
| December 31, 2023 | $398.03M | -44.0% | -10.0% |
- NEKTAR THERAPEUTICS showed a decrease of -7.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, NEKTAR THERAPEUTICS’s total assets has declined by 46.2% (from $521.23 million to $280.41 million).
- The most recent figure is from NEKTAR THERAPEUTICS’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: